Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00692562

Simultaneous Islet-Kidney Transplantation in Patients of Type 1 Diabetes With End-stage Renal Disease

Sponsor: Fuzhou General Hospital

Conditions End-stage Renal Disease Type 1 Diabetes Mellitus

Interventions simultaneous islet-kidney transplantation

Updated 5 times since 2017 Last updated: Sep 15, 2011 Started: Jun 30, 2005 Primary completion: Dec 31, 2006 Completion: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates End-stage Renal Disease and Type 1 Diabetes Mellitus and is currently completed. Fuzhou General Hospital leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Jun 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fuzhou General Hospital

Data source: Fuzhou General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fuzhou, China